FMP

FMP

Enter

Cerence Upgraded at Needham, Shares Rise 5%

-

twitterlinkedinfacebook
blog post cover photo

Image credit: FMP

Cerence Inc. (NASDAQ:CRNC) shares rose more than 5% pre-market today after the company received an upgrade from Needham analysts, who assigned a Buy rating and a price target of $16. This upgrade reflects optimism around the company’s potential to benefit from evolving voice technology and strategic industry trends.

The increasing adoption of large language model (LLM)-based voice assistants is expected to boost Cerence’s price-per-unit (PPU) metrics, aligning with automakers’ focus on cost efficiency while preserving their premium branding. According to the analysts, Cerence is well-positioned to capitalize on this convergence due to its innovative technology and market-leading solutions.

Needham cited several factors supporting the upgrade, including the company’s experienced leadership, effective debt management, and robust cash flow expectations driven by deferred revenue. Confidence in the continued rise of PPU rates and the normalization of fixed contract balances by late 2026 further strengthen the growth outlook. Additionally, operating expense estimates appear conservative, suggesting room for upside in near-term financial performance.

While the recent extension of Cerence’s partnership with NVIDIA was not the primary driver of the rating change, the collaboration is expected to bolster Cerence’s software capabilities in the short term. According to the analysts, over the longer term, this partnership could pave the way for unique edge LLM applications and an enhanced go-to-market strategy.

Other Blogs

Jan 22, 2025 8:26 AM - Davit Kirakosyan

Amazon Positioned for Strong Growth in 2025

Cantor Fitzgerald analysts reiterated an Overweight rating on Amazon.com (NASDAQ:AMZN), maintaining a price target of $270 on the stock. The outlook highlights Amazon’s robust positioning among mega-cap names, with potential upside in key metrics for both the fourth quarter of 2024 and the first qua...

blog post title

Jan 22, 2025 8:45 AM - Davit Kirakosyan

Johnson & Johnson Exceeds Q4 Expectations with Strong Oncology Demand

Johnson & Johnson (NYSE:JNJ) delivered fourth-quarter results that surpassed Wall Street expectations, driven by robust demand for its cancer treatments and strategic acquisitions. The pharmaceutical giant also provided an upbeat forecast for 2025, projecting full-year sales of $90.9 billion to $91....

blog post title
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep